Data gathered: July 5
AI Stock Analysis - Bio-Techne (TECH)
Analysis generated March 22, 2024. Powered by Chat GPT.
Bio Techne is a well-established company in the biotechnology industry, known for developing and manufacturing high-quality reagents, instruments, and consumables for research and diagnostic applications. With a broad product portfolio and a reputation for innovation, the company serves a global customer base spanning academic, biopharmaceutical, and clinical settings.
Stock Alerts - Bio-Techne (TECH)
 |
Bio-Techne | July 3 April Delaney (member of U.S. congress) is selling shares |
|
Bio-Techne | June 26 Business Outlook among employees is down by 3.9% over the last month. |
|
Bio-Techne | June 10 Over the past few months, there has been an downward trend in Web Traffic. |
|
Bio-Techne | May 21 Business Outlook among employees is down by 5.6% over the last month. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Bio-Techne
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 129 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 134,000 | Sign up | Sign up | Sign up |
| Employee Rating | 70 | Sign up | Sign up | Sign up |
| Google Trends | 20 | Sign up | Sign up | Sign up |
| Patents | 34 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 2,518 | Sign up | Sign up | Sign up |
| Instagram Followers | 1,604 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 650 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,320 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| Youtube Subscribers | 3,120 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 49 | Sign up | Sign up | Sign up |
| Linkedin Employees | 2,914 | Sign up | Sign up | Sign up |
About Bio-Techne
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide.
| Price | $53.14 |
| Target Price | Sign up |
| Volume | 842,920 |
| Market Cap | $8.33B |
| Year Range | $46.66 - $78.53 |
| Dividend Yield | 0.62% |
| PE Ratio | 64.02 |
| Analyst Rating | 71% buy |
| Industry | Biotechnology |
In the news
 |
Mirae Asset Global Investments Co. Ltd. Purchases 2,980 Shares of Bio-Techne Corp (NASDAQ:TECH)July 5 - ETF Daily News |
|
Bio-Techne Corp (NASDAQ:TECH) Shares Purchased by Janney Montgomery Scott LLCJuly 2 - ETF Daily News |
|
Bio-Techne Corp (NASDAQ:TECH) Shares Purchased by Diversified Trust CoJune 30 - ETF Daily News |
|
Bessemer Group Inc. Sells 61,323 Shares of Bio-Techne Corp (NASDAQ:TECH)June 30 - ETF Daily News |
 |
Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its StockJune 29 - Yahoo |
|
Asset Management One Co. Ltd. Has $8.01 Million Stock Holdings in Bio-Techne Corp (NASDAQ:TECH)June 28 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 316M | 102M | 215M | 23M | 39M | 0.560 |
| Q4 '24 | 297M | 103M | 194M | 35M | 75M | 0.420 |
| Q3 '24 | 289M | 106M | 183M | 34M | 74M | 0.420 |
| Q2 '24 | 306M | 101M | 205M | 41M | 97M | 0.490 |
| Q1 '24 | 303M | 98M | 205M | 49M | 99M | 0.480 |
Insider Transactions View All
| Herr Amy E. filed to sell 1,976 shares at $49.8. June 11 '25 |
| Herr Amy E. filed to sell 1,976 shares at $66. February 18 '25 |
| Kelderman Kim filed to sell 39,004 shares at $78. January 29 '25 |
| Kelderman Kim filed to sell 40,665 shares at $77.2. January 29 '25 |
| BAUMGARTNER ROBERT V filed to sell 43,401 shares at $72.1. August 12 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| April Delaney |
Jul 3, 25 | Sell | $1K - $15K |
| Julie Johnson |
May 15, 25 | Sell | $1K - $15K |
| April McClain Delaney |
May 2, 25 | Buy | $1K - $15K |
Read more about Bio-Techne (TECH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Bio-Techne?
The Market Cap of Bio-Techne is $8.33B.
What is Bio-Techne's PE Ratio?
As of today, Bio-Techne's PE (Price to Earnings) ratio is 64.02.
What is the current stock price of Bio-Techne?
Currently, the price of one share of Bio-Techne stock is $53.14.
How can I analyze the TECH stock price chart for investment decisions?
The TECH stock price chart above provides a comprehensive visual representation of Bio-Techne's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bio-Techne shares. Our platform offers an up-to-date TECH stock price chart, along with technical data analysis and alternative data insights.
Does TECH offer dividends to its shareholders?
Yes, Bio-Techne (TECH) offers dividends to its shareholders, with a dividend yield of 0.62%. This dividend yield represents Bio-Techne's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Bio-Techne in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Bio-Techne?
Some of the similar stocks of Bio-Techne are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.